Kate Rochlin - 01 Dec 2021 Form 3 Insider Report for IN8BIO, INC. (INAB)

Role
Chief Operating Officer
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
INAB
Transactions as of
01 Dec 2021
Net transactions value
$0
Form type
3
Filing time
10 Dec 2021, 15:41:38 UTC
Next filing
17 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INAB Employee Stock Option (right to buy) 01 Dec 2021 Common Stock 46,984 $6.74 Direct F1
holding INAB Employee Stock Option (right to buy) 01 Dec 2021 Common Stock 41,616 $5.36 Direct F2
holding INAB Employee Stock Option (right to buy) 01 Dec 2021 Common Stock 35,000 $10.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the shares subject to the option vested on October 1, 2021 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
F2 Twenty-five percent (25%) of the shares subject to the option shall vest on February 1, 2022 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
F3 One forty-eighth (1/48th) of the shares subject to the option shall vest monthly commencing on August 29, 2021, subject to the Reporting Person continuing to provide service through each such date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney